A pharmacy technician is researching a trade-name drug and one of its generic versions. Earlier that month, a study came out listing four new side effects that patients who used the generic drug experienced but that those using the trade-name drug did not. Which choice describes what could result from the new research?
A. The trade-name drug will develop a new bioequivalent to keep costs low.
B. The CDC will need to add the generic drug to the Orange Book.
C. The drug company will need to decrease the potency of the generic drug.
D. The generic drug is no longer the therapeutic equivalent of the trade-name drug.
